Coronary heart disease in patients with end-stage renal disease on maintenance dialysis. Part I: Epidemiology, pathology of atherosclerosis, and diagnosis;Choroba niedokrwienna serca u chorych leczonych nerkozastępczo. Częs̈ć I. Epidemiologia, patologia zmian miazdzycowych, diagnostyka

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 60, Issue , 2006, Pages 286-289

  Gołębiowski, Tomasz ^a   Weyde, Wacław ^a   Krajewska, Magdalena ^a   Kazimierczak, Krzysztof ^a   Derkacz, Arkadiusz ^b   Nowicki, Przemysław ^b   Klinger, Marian ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Medical University of Lublin Katedra i Klinika Kardiologii   (Poland)

Author keywords

Atherosclerosis; Coronary hart disease; End stage renal disease; Kidney transplantation

Indexed keywords

CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; MORTALITY; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; STATISTICS;

CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; ENGLISH ABSTRACT; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RISK FACTORS;

EID: 33845919028     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Biesenbach G., Zazgornik J.: Influence of smoking on the survival rate of diabetic patients requiring hemodialysis. Diabetes Care, 1996; 19: 625-628
2. Bostom A.G., Lathrop L.: Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int., 1997; 52: 10-20
3. Boudreau R.J., Strony J.T., duCret R.P., Kuni C.C., Wang Y., Wilson R.F., Schwartz J.S., Castaneda-Zuniga W.R.: Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology, 1990; 175: 103-105
4. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G.: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 1995, 274: 1049-1057
5. Braun W.E., Phillips D.F., Vidt D.G., Novick A.C., Nakamoto S., Popowniak K.L., Paganini E., Magnusson M., Pohl M., Steinmuller D.R. Et al.: Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant. Proc., 1984; 16: 603-607
6. Cressman M.D., Heyka R.J., Paganini E.P., O'Neil J., Skibinski C.I., Hoff H.F.: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation, 1992; 86: 475-482
7. Dahan M., Viron B.M., Faraggi M., Himbert D.L., Lagallicier B.J., Kolta A.M., Pessione F., Le Guludec D., Gourgon R., Mignon F.E.: Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int., 1998; 54: 255-262
8. De Lima J.J., Sabbaga E., Vieira M.L., de Paula F.J., Ianhez L.E., Krieger E.M., Ramires J.A.: Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing. Hypertension, 2003; 42: 263-268
9. Duman D., Tokay S., Toprak A., Duman D., Oktay A., Ozener I.C., Unay O.: Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients. Nephrol. Dial. Transplant., 2005; 20: 962-967
10. Foley R.N., Parfrey P.S., Sarnak M.J.: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis., 1998; 32: S112-S119
11. Frustaci A., Gentiloni N., Chimenti C., Natale L., Gasbarrini G., Maseri A.: Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest, 1998; 114: 1484-1489
12. Gibbons R.J., Abrams J., Chatterjee K., Daley J., Deedwania P.C., Douglas J.S., Ferguson T.B. Jr, Fihn S.D., Fraker T.D. Jr, Gardin J.M., O'Rourke R.A., Pasternak R.C., Williams S.V., American College of Cardiology; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina): ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J. Am. Coll. Cardiol., 2003; 41: 159-168
13. Gradaus F., Ivens K., Peters A.J., Heering P., Schoebel F.C., Grabensee B., Strauer B.E.: Angiographic progression of coronary artery disease in patients with end-stage renal disease. Nephrol. Dial. Transplant., 2001; 16: 1198-1202
14. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Palma-Reis R.J., Boers G.H., Sheahan R.G., Israelsson B., Uiterwaal C.S., Meleady R., McMaster D., Verhoef P., Witteman J., Rubba P., Bellet H., Wautrecht J.C., de Valk H.W., Sales Luis A.C., Parrot-Rouland F.M., Tan K.S., Higgins I., Garcon D., Andria G. Et al.: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA, 1997; 277: 1775-1781
15. Herzog C.A.: Cardiovascular disease and dialysis patients: Is therapeutic nihilism justified? Semin. Dialysis, 1999; 12: 285-287
16. Herzog C.A., Ma J.Z., Collins A.J.: Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am. J. Kidney Dis., 2000; 36: 145-152
17. Herzog C.A., Ma J.Z., Collins A.J.: Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med., 1998; 339: 799-805
18. Jung H.H., Ma K.R., Han H.: Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients. Nephrol. Dial. Transplant., 2004; 19: 3117-3123
19. Kalantar-Zadeh K., Block G., Humphreys M.H., McAllister C.J., Kopple J.D.: A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J. Am. Soc. Nephrol., 2004; 15: 442-453
20. Kalousova M., Sulkova S., Fialova L., Soukupova J., Malbohan I.M., Spacek P., Braun M., Mikulikova L., Fortova M., Horejsi M., Tesar V., Zima T.: Glycoxidation and inflammation in chronic haemodialysis patients. Nephrol. Dial. Transplant., 2003; 18: 2577-2581
21. Kasiske B.L.: Hyperlipidemia in patients with chronic renal disease. Am. J. Kidney Dis., 1998; 32: S142-S156
22. Liu Y., Coresh J., Eustace J.A., Longenecker J.C., Jaar B., Fink N.E., Tracy R.P., Powe N.R., Klag M.J.: Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA, 2004; 291: 451-459
23. Marwick T.H., Steinmuller D.R., Underwood D.A., Hobbs R.E., Go R.T., Swift C., Braun W.E.: Ineffectiveness of dipyridamole SPECT thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure. Transplantation, 1990; 49: 100-103
24. Miyazaki H., Matsuoka H., Itabe H., Usui M., Ueda S., Okuda S., Imaizumi T.: Hemodialysis impairs endothelial function via oxidative stress: effects of Vitamin E-coated dialyzer. Circulation, 2000; 101: 1002-1006
25. Morbini P., Dal Bello B., Arbustini E.: Coronary artery inflammation and thrombosis in Wegener's granulomatosis-polyarteritis nodosa overlap syndrome. G. Ital. Cardiol., 1998; 28: 377-382
26. Morena M., Cristol J.P., Senecal L., Leray-Moragues H., Krieter D., Canaud B.: Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit? Kidney Int. Suppl., 2002; 80: 109-114
27. Murphy S.W., Parfrey P.S.: Screening for cardiovascular disease in dialysis patients. Curr. Opin. Nephrol. Hypertens., 1996; 5: 532-540
28. Nakai K., Nakai K., Nagane Y., Obara W., Sato M., Ohi K., Matsumoto N., Takanashi N., Itoh C.: Serum levels of cardiac troponin I and other marker proteins in patients with chronic renal failure. Clin. Exp. Nephrol., 2004; 8: 43-47
29. National Institute of Diabetes and Digestive and Kidney Diseases. Renal Data System. USRDS 2000 Annual Data Report. (NIH publication no.00-3176), 583-689. 2000. Bethesda MD. Http://www.niddk. Nih.gov/, http://www.usrds.org/adr.htm
30. Rostand S.G., Kirk K.A., Rutsky E.A.: The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. Contrib. Nephrol., 1986; 52: 34-41
31. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., Palacios I.F.: Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation., 2000; 102: 2966-2972
32. Schwarz U., Amann K., Ritz E.: Why are coronary plaques more malignant in the uraemic patient? Nephrol. Dial. Transplant., 1999; 14: 224-225
33. Schwarz U., Buzello M., Ritz E., Stein G., Raabe G., Wiest G., Mall G., Amann K.: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol. Dial. Transplant., 2000; 15: 218-223
34. Takahashi M.: Inflammatory diseases of the coronary artery in children. Coron. Artery Dis., 1993; 4: 133-138
35. Tovbin D., Mazor D., Vorobiov M., Chaimovitz C., Meyerstein N.: Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation. Am. J. Kidney Dis., 2002; 40:1005-1012
36. Urso S., Garozzo M., Milone F., Battaglia G.: Cardiovascular risk markers in hemodialysis patients. Int. J. Artif. Organs, 2004; 27: 1083-1090
37. Vandenberg B.F., Rossen J.D., Grover-McKay M., Shammas N.W., Burns T.L., Rezai K.: Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods. Transplantation, 1996; 62: 1230-1235
38. Vanholder R., Glorieux G., Lameire N.: Uraemic toxins and cardiovascular disease Nephrol. Dial. Transplant., 2003; 18: 463-466
39. Vos J., de Feyter P.J., Kingma J.H., Emanuelsson H., Legrand V., Winkelmann B., Dumont J.M., Simoons L.M.: Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. The Multicenter Anti-Atheroma Study (MAAS) Investigators. Eur. Heart J., 1997; 18: 1081-1089